溃疡性结肠炎伴低级别异型增生患者结直肠癌的发生率、危险因素与结局:系统综述与荟萃分析
本系统综述与荟萃分析纳入14项监测队列研究共671例溃疡性结肠炎伴低级别异型增生(UC-LGD)患者,结直肠癌(CRC)年发病率为0.8%(95%CI 0.4-1.3),进展为进展期肿瘤的年发病率为1.8%(95%CI 0.9-2.7);在12项手术队列研究共450例因UC-LGD行结肠切除术的患者中,同时性CRC的合并患病率为17%(95%CI 8-33)。专家胃肠病理医师诊断的LGD患者CRC风险(1.5%)高于社区病理医师诊断者(0.2%)。合并原发性硬化性胆管炎、不可见异型增生、远端位置和多灶性LGD是与异型增生进展显著相关的危险因素。
要点
- UC-LGD监测队列中CRC年发病率为0.8%(95%CI 0.4-1.3),进展期肿瘤年发病率为1.8%(95%CI 0.9-2.7)。
- 因UC-LGD行结肠切除术的患者中同时性CRC合并患病率为17%(95%CI 8-33)。
- 合并原发性硬化性胆管炎、不可见异型增生、远端位置和多灶性LGD与异型增生进展显著相关。
核心结论
- 在UC-LGD监测患者中,进展为CRC的年发病率为0.8%;LGD诊断率的差异随病理医师专业水平而异。
- 合并原发性硬化性胆管炎、不可见异型增生、远端位置和多灶性LGD是与异型增生进展相关的高危特征。
研究设计与样本
- 系统文献综述检索至2016年6月1日,纳入成人UC-LGD队列研究。
- 监测队列共14项研究、671例UC-LGD患者,其中52例发生CRC。
- 手术队列共12项研究、450例因UC-LGD行结肠切除术的患者,其中34例有同时性CRC。
主要发现
- 监测队列中CRC合并年发病率为0.8%(95%CI 0.4-1.3),进展期肿瘤合并年发病率为1.8%(95%CI 0.9-2.7)。
- 专家胃肠病理医师诊断LGD者CRC风险为1.5%,社区病理医师诊断者为0.2%。
- 与异型增生进展显著相关的因素:合并原发性硬化性胆管炎(OR 3.4;95%CI 1.5-7.8)、不可见异型增生(vs 可见异型增生;OR 1.9;95%CI 1.0-3.4)、远端位置(vs 近端位置;OR 2.0;95%CI 1.1-3.7)、多灶性异型增生(vs 单灶性异型增生;OR 3.5;95%CI 1.5-8.5)。
- 手术队列中同时性CRC合并患病率为17%(95%CI 8-33)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Little is known about outcomes of patients with ulcerative colitis with low-grade dysplasia (UC-LGD). We estimated the incidence of and risk factors for progression to colorectal cancer (CRC) in cohorts of patients with UC-LGD who underwent surveillance (surveillance cohort), and the prevalence of dysplasia-related findings among patients who underwent colectomy for UC-LGD (surgical cohort). METHODS: We performed a systematic literature review through June 1, 2016, to identify cohort studies of adults with UC-LGD. We estimated pooled incidence rates of CRC and risk factors associated with dysplasia progression in surveillance cohorts, and prevalence of synchronous advanced neoplasia (CRC and/or high-grade dysplasia) in surgical cohorts. RESULTS: In 14 surveillance cohort studies of 671 patients with UC-LGD (52 developed CRC), the pooled annual incidence of CRC was 0.8% (95% confidence interval [CI], 0.4-1.3); the pooled annual incidence of advanced neoplasia was 1.8% (95% CI, 0.9-2.7). Risk of CRC was higher when LGD was diagnosed by expert gastrointestinal pathologist (1.5%) than by community pathologists (0.2%). Factors significantly associated with dysplasia progression were concomitant primary sclerosing cholangitis (odds ratio [OR], 3.4; 95% CI, 1.5-7.8), invisible dysplasia (vs visible dysplasia; OR, 1.9; 95% CI, 1.0-3.4), distal location (vs proximal location; OR, 2.0; 95% CI, 1.1-3.7), and multifocal dysplasia (vs unifocal dysplasia; OR, 3.5; 95% CI, 1.5-8.5). In 12 surgical cohort studies of 450 patients who underwent colectomy for UC-LGD, 34 patients had synchronous CRC (pooled prevalence, 17%; 95% CI, 8-33). CONCLUSION: In a systematic review of the literature, we found that among patients with UC-LGD under surveillance, the annual incidence of progression to CRC was 0.8%; differences in rates of LGD diagnosis varied with pathologists' level of expertise. Concomitant primary sclerosing cholangitis, invisible dysplasia, distal location, and multifocal LGD are high-risk features associated with dysplasia progression.
引用
- Fumery M, Dulai PS, Gupta S, et al. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2016. PMID: 27916678. doi:10.1016/j.cgh.2016.11.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。